These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35984789)

  • 1. Epidemic Vulnerability Index for Effective Vaccine Distribution Against Pandemic.
    Lee H; Kang M; Kim D; Seo D; Li Y
    IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(6):3332-3342. PubMed ID: 35984789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study.
    Wang T; Li C; Li H; Li Z
    BMJ Open; 2022 Jul; 12(7):e057281. PubMed ID: 35831042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is COVID-19 vaccine inequality undermining the recovery from the COVID-19 pandemic?
    Suárez-Álvarez A; López-Menéndez AJ
    J Glob Health; 2022 May; 12():05020. PubMed ID: 35604879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between vaccine coverage and the COVID-19 pandemic throughout the world: Based on real-world data.
    Huang C; Yang L; Pan J; Xu X; Peng R
    J Med Virol; 2022 May; 94(5):2181-2187. PubMed ID: 35075651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
    Pearson CAB; Bozzani F; Procter SR; Davies NG; Huda M; Jensen HT; Keogh-Brown M; Khalid M; Sweeney S; Torres-Rueda S; ; ; Eggo RM; Vassall A; Jit M
    PLoS Med; 2021 Oct; 18(10):e1003815. PubMed ID: 34606520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The COVID-19 Vaccination and Vaccine Inequity Worldwide: An Empirical Study Based on Global Data.
    Ning C; Wang H; Wu J; Chen Q; Pei H; Gao H
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023.
    Kim RK; Choe YJ; Jang EJ; Chae C; Hwang JH; Lee KH; Shim JA; Kwon GY; Lee JY; Park YJ; Lee SW; Kwon D
    J Korean Med Sci; 2023 Nov; 38(46):e396. PubMed ID: 38013649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies.
    Fu Y; Zhao J; Wei X; Han P; Yang L; Ren T; Zhan S; Li L
    Front Public Health; 2022; 10():917732. PubMed ID: 35928479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.
    Vasileiou E; Simpson CR; Shi T; Kerr S; Agrawal U; Akbari A; Bedston S; Beggs J; Bradley D; Chuter A; de Lusignan S; Docherty AB; Ford D; Hobbs FR; Joy M; Katikireddi SV; Marple J; McCowan C; McGagh D; McMenamin J; Moore E; Murray JL; Pan J; Ritchie L; Shah SA; Stock S; Torabi F; Tsang RS; Wood R; Woolhouse M; Robertson C; Sheikh A
    Lancet; 2021 May; 397(10285):1646-1657. PubMed ID: 33901420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic.
    Wang Y; Luangasanatip N; Pan-Ngum W; Isaranuwatchai W; Prawjaeng J; Saralamba S; Painter C; Briones JR; Teerawattananon Y
    Eur J Health Econ; 2023 Jul; 24(5):735-748. PubMed ID: 35951243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A flexible age-dependent, spatially-stratified predictive model for the spread of COVID-19, accounting for multiple viral variants and vaccines.
    Schneider KA; Tsoungui Obama HCJ; Adil Mahmoud Yousif N
    PLoS One; 2023; 18(1):e0277505. PubMed ID: 36662784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccine attitudes among a majority black sample in the Southern US: public health implications from a qualitative study.
    Huang W; Dove-Medows E; Shealey J; Sanchez K; Benson L; Seymore DD; Sullivan PS; Bradley HM; Siegler AJ
    BMC Public Health; 2023 Jan; 23(1):88. PubMed ID: 36631819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of Preferences for COVID-19 Vaccines in Hungary Based on Their Properties-Examining the Impact of Pandemic Awareness with a Hybrid Choice Approach.
    Blaga Z; Czine P; Takacs B; Szilagyi A; Szekeres R; Wachal Z; Hegedus C; Buchholcz G; Varga B; Priksz D; Bombicz M; Szabo AM; Kiss R; Gesztelyi R; Romanescu DD; Szabo Z; Szucs M; Balogh P; Szilvassy Z; Juhasz B
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An equitable vaccine delivery system: Lessons from the COVID-19 vaccine rollout in Canada.
    Kholina K; Harmon SHE; Graham JE
    PLoS One; 2022; 17(12):e0279929. PubMed ID: 36584230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abrupt transition of the efficient vaccination strategy in a population with heterogeneous fatality rates.
    Jhun B; Choi H
    Chaos; 2022 Sep; 32(9):093140. PubMed ID: 36182386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "They're trying to bribe you and taking away your freedoms": COVID-19 vaccine hesitancy in communities with traditionally low vaccination rates.
    Capurro G; Maier R; Tustin J; Jardine CG; Michelle Driedger S
    Vaccine; 2022 Nov; 40(50):7280-7287. PubMed ID: 36334965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: The case of COVID-19.
    Zhu J; Wang Q; Huang M
    Front Public Health; 2023; 11():1129183. PubMed ID: 37168073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of elderly individuals' perceptions and attitudes toward COVID-19 pandemic on rejecting COVID-19 vaccination.
    Beyazgul B; Koruk İ; Kuzan R
    Hum Vaccin Immunother; 2022 Nov; 18(5):2079338. PubMed ID: 35687362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.
    Patel MD; Rosenstrom E; Ivy JS; Mayorga ME; Keskinocak P; Boyce RM; Hassmiller Lich K; Smith RL; Johnson KT; Delamater PL; Swann JL
    JAMA Netw Open; 2021 Jun; 4(6):e2110782. PubMed ID: 34061203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.